trimethoprim-sulfamethoxazole. MICs of antimicrobial agents determined by E-test disc diffusion were as follows (mg ml 21 ):
cefotaxime, 256; ceftazidime, 256; aztreonam, 256; cefoxitin, .256; imipenem, 16; meropenem, 16; gentamicin, 1024; tobramycin, 1024; amikacin, .256; ciprofloxacin, .256; trimethoprim-sulfamethoxazole, .32; and tetracycline, 4 . PCR and DNA sequencing were used for detecting the antimicrobialresistance genes, including b-lactamase genes, plasmid-borne quinolone-resistance determinants, and 16S rRNA methylase genes. bla KPC-2 was found in C. freundii strain NC118 by PCR and direct DNA sequencing of both strands with an ABI PRISM 3100 genetic analyser (Applied Biosystems). qnr genes including qnrA, qnrB and qnrS were determined by multiplex PCR as described previously (Robicsek et al., 2006) . C. freundii strain NC118 was positive for qnrA and qnrB. qnrA-and qnrB-positive PCR products were sequenced and shown to match qnrA1 and qnrB1. aac(69)-Ib-cr was detected in the isolate by PCR and direct DNA sequencing (Park et al., 2006a) . Extended-spectrum b-lactamase genes were screened by PCR as described previously (Yu et al., 2007) . DNA sequencing of both strands was performed by the direct sequencing method. bla TEM-1 , bla CTX-M-3 and bla CTX-M-14 were found. Since C. freundii strain NC118 was highly resistant to cefoxitin (MIC .256 mg ml 21 ), plasmid-borne AmpC-lactamase genes were sought by using a multiplex PCR as described previously (Perez-Perez & Hanson, 2002 16S rRNA methylase genes, including armA, rmtA, rmtB, rmtC, rmtD and npmA, were determined by PCR and DNA sequencing as described previously (Yu et al., 2009) . Only armA was found in the isolate. In order to determine whether the plasmid-bearing resistance was transferable, a conjugation experiment was carried out in Luria-Bertani broth with Escherichia coli J53 as the recipient. Transconjugants were selected on tryptic soy agar plates containing sodium azide (100 mg ml 21 ) for counterselection and ampicillin (10 mg ml
21
), ciprofloxacin (0.5 mg ml
) and amikacin (10 mg ml
) to select for plasmid-encoded resistance. Repeated attempts to acquire transconjugants containing plasmid-encoded resistance were unsuccessful. Plasmid DNA of C. freundii strain NC118 was extracted with the Qiagen Plasmid Midi kit according to the manufacturer's instructions. A transformation experiment was used to further investigate plasmid-encoded resistance. Cefotaxime (10 mg ml 21 ), cefoxitin (10 mg ml 21 ), ciprofloxacin (0.5 mg ml 21 ) and amikacin (10 mg ml 21 ) were used for selecting transformants with plasmidencoded resistance determinants. Although the transformants harbouring quinoloneresistance determinants bla CTX-M , bla KPC-2 and armA were obtained, acquiring the transformant harbouring bla CMY-49 was unsuccessful after repeated attempts. bla CMY-49 was probably located on the chromosome of C. freundii strain NC118. The presence of class 1 integrons was determined by PCR with primers 59CS (59-GGCATCCAAGCAGCAAGC-39) and 39CS (59-AAGCAGACTTGACCTGAT-39) located in the 59 and 39 conserved segments. Only an approximate 2 kb PCR fragment was obtained from the isolate. The class 1 integron contained a 59 conserved region, dfrA12 associated with resistance to trimethoprim, orfF, aadA2 conferring resistance to streptomycin and spectinomycin antibiotics and a 39 conserved region.
bla KPC-2 has been found coexisting with extended-spectrum b-lactamase genes and ampC in C. freundii isolates from several countries including China (Rasheed et al., 2008; Zhang et al., 2008) . 16S rRNA methylase genes and plasmid-borne quinolone-resistance determinants have also been found in C. freundii isolates (Park et al., 2006b; Tamang et al., 2008) . However, bla KPC-2 coexisting with 16S rRNA methylase genes and plasmid-borne quinolone-resistance determinants in the same C. freundii strain has not been reported before to our knowledge.
In conclusion, a total of 11 antimicrobialresistance genes, bla KPC-2 , qnrA1, qnrB1, aac(69)-Ib-cr, bla TEM-1 , bla CTX-M-3, bla CTX-M-14 , armA, aadA2, dfrA12 and bla CMY-49 , were simultaneously detected in C. freundii strain NC118, which resulted in C. freundii strain NC118 being resistant to most of the clinically used antimicrobial agents.
